Sucralfate 1 gram
Pro Research Analysisby 
Searched over 200M research papers
Efficacy and Usage of Sucralfate 1 Gram in Gastrointestinal Treatments
Sucralfate 1 Gram for Gastric Ulcer Healing
Sucralfate, a basic aluminum salt of sulfated sucrose, is widely used in the treatment of peptic ulcer disease due to its ability to protect the ulcer site from pepsin, acid, and bile salts. A comparative study evaluated the effectiveness of sucralfate 1 gram administered four times daily (q.i.d.) versus 2 grams administered twice daily (b.i.d.) in healing benign gastric ulcers. The study found that both regimens were similarly effective, with healing rates of 59% and 71% for the 1 gram q.i.d. regimen at 8 and 12 weeks, respectively, compared to 67% and 92% for the 2 grams b.i.d. regimen . This suggests that sucralfate 1 gram q.i.d. is a viable option for gastric ulcer treatment.
Sucralfate 1 Gram for NSAID-Induced Gastrointestinal Damage
Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to cause gastrointestinal symptoms and mucosal damage. A randomized, double-blind trial assessed the efficacy of sucralfate 1 gram q.i.d. in treating these conditions. The study demonstrated that sucralfate significantly reduced the frequency and intensity of peptic symptoms and improved gastric mucosal lesions compared to placebo. Long-term use of sucralfate continued to show improvement in gastrointestinal symptoms and lesion scores, indicating its effectiveness in managing NSAID-induced gastrointestinal damage .
Sucralfate 1 Gram in Duodenal Ulcer Treatment
Sucralfate has also been tested for its efficacy in treating duodenal ulcers. In a multicenter, double-blind, placebo-controlled study, patients treated with sucralfate 1 gram q.i.d. showed a significant healing rate of 91.7% after four weeks, compared to 58.1% in the placebo group. This highlights sucralfate's effectiveness in promoting duodenal ulcer healing . Another study comparing sucralfate 1 gram q.i.d. with 2 grams b.i.d. found similar healing rates, suggesting that the more convenient twice-daily regimen could be as effective as the four-times-daily regimen .
Sucralfate 1 Gram for Radiation-Induced Oral Mucositis
In patients undergoing radiation therapy for head and neck malignancies, sucralfate has been evaluated for its potential to prevent oral mucositis. A study involving 44 patients found that sucralfate, administered in six daily doses of 1 gram, significantly reduced oral mucositis scores and oral pain. Histopathological evaluations also showed reduced vascular alterations and leukocyte emigration, indicating that sucralfate can effectively mitigate radiation-induced oral mucositis .
Sucralfate 1 Gram for Gastric Microbleeding
Sucralfate's protective effects extend to reducing gastric microbleeding. A double-blind, placebo-controlled trial involving healthy male subjects demonstrated that sucralfate 1 gram q.i.d. significantly reduced spontaneous gastric microbleeding and DNA loss. In aspirin-treated subjects, sucralfate prevented blood loss, although it did not affect DNA loss. The study concluded that sucralfate's protective action might be partly due to increased mucosal biosynthesis of prostaglandins .
Conclusion
Sucralfate 1 gram administered four times daily is effective in treating various gastrointestinal conditions, including gastric and duodenal ulcers, NSAID-induced gastrointestinal damage, radiation-induced oral mucositis, and gastric microbleeding. Its efficacy is comparable to higher doses administered less frequently, making it a versatile and well-tolerated option for managing peptic ulcer disease and related conditions.
Sources and full results
Most relevant research papers on this topic
Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
Sucralfate therapy, 1 g four times daily, effectively reduces gastrointestinal symptoms and gastric mucosal damage associated with NSAIDs, allowing patients to continue therapy.
Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial.
Sucralfate effectively treats duodenal ulcers, with 91.75% of patients showing complete healing and relief from ulcer discomfort after 4 weeks of treatment.
Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
Sucralfate effectively reduces spontaneous and aspirin-induced gastric microbleeding in men, partly due to increased mucosal prostaglandin biosynthesis.
Sucralfate as an Adjunct to Analgesia to Improve Oral Intake in Children With Infectious Oral Ulcers: A Randomized, Double-Blind, Placebo-Controlled Trial.
Sucralfate as an adjunct to oral analgesics did not significantly improve oral intake in children with acute oral infectious ulcers.
Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial.
Oral sucralfate does not reduce acute radiation-induced side-effects in head and neck cancer patients treated by radiotherapy, and its prophylactic use is not recommended.
DOI